Showing results for Indianapolis Campus

IU School of Medicine scientists have discovered a potential new strategy to combat leukemia through a special approach that targets both cancer cells and their ...

IU School of Medicine researchers aim to develop a new treatment for neurodegeneration by targeting an immune cell-specific gene associated with Alzheimer's disease.

A new clinical trial, the first of its kind, showed positive outcomes for certain Type 1 diabetes patients when taking semaglutide once per week. 

IU School of Medicine researchers are studying how rapid DNA sequencing technology can help improve treatment for fracture-related infections, a serious health complication that can ...

A trio of studies led by IU School of Medicine researchers found digital testing during primary care visits showed some promise as a tool for early identification of Alzheimer’s disease and dementia in older adults.

Wade Clapp is partnering with Healx to use artificial intelligence to develop novel treatments for shrinking the plexiform neurofibromas found in NF1. 

The transformative gift from the Lechleiter and Tobias families to IU Health and IU School of Medicine aims to advance healthcare discovery to benefit patients ...

Over the 2024-25 school year, aspiring physicians and biomedical researchers worked in one of the many research labs at the IU School of Medicine, mentored ...

Class of 2025 includes 354 MD, 38 PhD graduates

The Chuckstrong initiative has enabled the IU Simon Comprehensive Cancer Center to accelerate cancer research by recruiting top-level researchers and purchasing sophisticated laboratory instruments to ...